期刊文献+

自噬在角膜病中的作用及调节自噬的潜在治疗效果 被引量:2

The role of autophagy and potential therapeutic effect of autophagy regulation in cornea diseases
下载PDF
导出
摘要 自噬是由溶酶体介导的降解受损蛋白质或衰老细胞器的代谢过程,对维持细胞内环境稳定、实现细胞自身代谢及循环更新具有重要作用。近年来的研究表明,自噬与许多眼部疾病,包括白内障、青光眼、视网膜脱离、糖尿病视网膜病变和年龄相关性黄斑变性等的发生和发展密切相关。在颗粒状角膜营养不良2型(GCD2)、Fuchs角膜内皮营养不良(FECD)、角膜炎、圆锥角膜(KC)、角膜损伤及修复、干眼等角膜病中,自噬紊乱会影响角膜的透明性,甚至致盲,调节自噬活性可能成为治疗角膜病的研究热点之一。本文就自噬在角膜病中的作用及调节自噬的潜在治疗效果进行综述。 Autophagy is a metabolic process of lysosomal-mediated degradation of damaged proteins or aging organelles,which plays an important role in maintaining the stability of intracellular environment and achieving cell metabolism and circulation.Recent studies have shown that autophagy is closely related to the development of many ocular diseases,including cataract,glaucoma,retinal detachment,diabetic retinopathy and age-related macular degeneration.In keratopathy,including granular corneal dystrophy type 2(GCD2),Fuchs corneal endothelium dystrophy(FECD),keratitis,keratoconus(KC),corneal injury and repair,dry eye and so on,autophagic disorder can affect corneal transparency,and even lead to blindness.Regulating autophagic activity may be one of the hotspots in the study of corneal disease.This article reviews the role of autophagy and the potential therapeutic effect of autophagy regulation in cornea diseases.
作者 邹雪香(综述) 李娟(审校) Zou Xuexiang;Li Juan(Shaanxi Ophthalmic Medical Center,Department of Ophthalmology,Xi'an No.4 Hospital,Affiliated Guangren Hospital,School of Medicine,Xi'an Jiaotong University,Xi'an 710004,China;Sixth Affiliated Hospital of Guangzhou Medical University,Department of Ophthalmology,Qingyuan People's Hospital,Qingyuan 511518,China)
出处 《中华实验眼科杂志》 CAS CSCD 北大核心 2019年第2期129-133,共5页 Chinese Journal Of Experimental Ophthalmology
基金 国家自然科学基金项目(81400424) 陕西省科学技术研究发展计划项目(2014K11-03-07-04) 陕西省人才推进计划项目-青年科技新星项目(2017KJXX-87).
关键词 自噬 角膜病 治疗 Autophagy Cornea diseases Therapy
  • 相关文献

参考文献5

二级参考文献54

  • 1夏丽坤,张劲松,陈晓隆,王爱媛.细胞因子在鼠复发性单纯疱疹性角膜基质炎角膜组织中的表达[J].中华眼科杂志,2005,41(5):403-408. 被引量:19
  • 2Cornu M, Albert V, Hall MN. mTOR in aging, metabolism, and cancer [J]. Curr Opin Genet Dev,2013,23(1) :53-62. doi:10. 1016/j. gde. 2012.12. 005.
  • 3Heitman J, Movva NR, Hall MN. Tagets for cell cycle arrest by the immunosuppressant rapamyein in yeast [ J ]. Science, 1991,253 ( 5022 ) : 905 -909.
  • 4Takei N ,Nawa H. mTOR signaling and its roles in normal and abnormal brain development[ J/OL]. Front Mol Neurosci ,2014,7 : 28 [ 2015 -06 - 14 ]. http://journal, frontiersin, org/artiele/10. 3389/fnmol. 2014. 00028. doi: 10. 3389/fnmol. 2014. 00028.
  • 5Shields CL, Shields JA. Recent developments in the management of retinoblastoma[ J]. J Pediatr Ophthalmol Strabismus,1999,36( 1 ) :8-18.
  • 6Cafferkey R, Young PR, McLaughlin MM, et al. Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity[ J]. Mol Cell Biol, 1993,13(10) :6012-6023. doi:10, l128/MCB. 13.10.6012.
  • 7Gibbons JJ, Abraham RT, Yu K. Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth [ J ]. Semin Oncol, 2009,36 Suppl 3 : $3 - S17. doi : 10. 1053/j. seminoncol. 2009.10. O11.
  • 8Laplante M ,Sabatini DM. mTOR signaling at a glance[ J]. J Cell Sci, 2009,122(Pt 20) :3589-3594. doi:lO. 1242/jcs. 051011.
  • 9Parkhitko AA, Favorova OO, Khabibullin DI, et al. Kinase mTOR: regulation and role in maintenance of cellular homeostasis, tumor development, and aging[ J ]. Biochemistry, 2014,79 ( 2 ) : 88 - 101. doi : 10.1134/S0006297914020023.
  • 10Sarbassov DD, Guertin DA, Ali SM, et al. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex [ J 1 ~ Science, 2005,307(5712) : 1098-1101.

共引文献52

同被引文献29

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部